Moreover, the identification of NK subsets expressing DNAM1 as pivotal to expedited recovery from SARS-CoV-2 infection [38] opens avenues for novel therapeutic strategies in COVID-19 management, particularly pertinent when the disease is complicated by T2D. The gene discussed is CD226; the disease is COVID-19.